Susceptibility of oral bacteria to Melaleuca alternifolia (tea tree) oil in vitro

Oral Microbiology and Immunology

Volumn 18, Issue 6, 2003, Pages 389-392

  Hammer, Katherine A ^a   Dry, L ^a   Johnson, M ^b   Michalak, E M ^a   Carson, C F ^a   Riley, T V ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Melaleuca alternifolia; Minimum inhibitory concentration; Tea tree oil; Time kill

Indexed keywords

TEA TREE OIL;

ACTINOMYCES; ANTIBACTERIAL ACTIVITY; ARTICLE; FUSOBACTERIUM; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; MINIMUM INHIBITORY CONCENTRATION; MOUTH FLORA; NONHUMAN; PREVOTELLA; STREPTOCOCCUS MITIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS SANGUINIS; VEILLONELLA;

ACTINOMYCES; ANTI-INFECTIVE AGENTS, LOCAL; FUSOBACTERIUM; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; LACTOBACILLUS; MICROBIAL SENSITIVITY TESTS; MOUTH; PORPHYROMONAS; PREVOTELLA; STREPTOCOCCUS MITIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS SANGUIS; TEA TREE OIL; TIME FACTORS; VEILLONELLA;

EID: 0242642277     PISSN: 09020055     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0902-0055.2003.00105.x     Document Type: Article

References (24)

1. Arweiler NB, Donos N, Netuschil L, Reich E. Clinical and antibacterial effect of tea tree oil - a pilot study. Clin Oral Invest 2000: 4: 70-73.
2. Bassett IB, Pannowitz DL, Barnetson RStC. A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Med J Aust 1990: 153: 455-458.
3. Brand C, Ferrante A, Prager RH, Riley TV, Carson CF, Finlay-Jones JJ, et al. The water soluble components of the essential oil of Melaleuca alternifolia (tea tree oil), suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro. Inflamm Res 2001: 50: 213-219.
4. Brophy JJ, Davies NW, Southwell IA, Stiff IA, Williams LR. Gas chromatographic quality control for oil of Melaleuca terpinen-4-ol type (Australian tea tree). J Agric Food Chem 1989: 37: 1330-1335.
5. Carson CF, Riley TV. Antimicrobial activity of the essential oil of Melaleuca alternifolia. Lett Appl Microbiol 1993: 16: 49-55.
6. Carson CF, Ashton L, Dry L, Smith DW, Riley TV. Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis. J Antimicrob Chemother 2001: 48: 450-451.
7. Darout IA, Albandar JM, Skaug N. Periodontal status of adult Sudanese habitual users of miswak chewing sticks or toothbrushes. Acta Odontol Scand 2000: 58: 25-30.
8. Fine DH, Furgang D, Barnett ML, Drew C, Steinberg L, Charles CH, et al. Effect of an essential oil-containing antiseptic mouthrinse on plaque and salivary Streptococcus mutans levels. J Clin Periodontol 2000: 27: 157-161.
9. Groppo FC, Ramacciato JC, Simoes RP, Florio FM, Sartoratto A. Antimicrobial activity of garlic, tea tree oil, and chlorhexidine against oral microorganisms. Int Dent J 2002: 52: 433-437.
10. Hammer KA, Carson CF, Riley TV. In vitro susceptibilities of lactobacilli and organisms associated with bacterial vaginosis to Melaleuca alternifolia (tea tree) oil. Antimicrob Agents Chemother 1999: 43: 196.
11. Hammer KA, Carson CF, Riley TV. Influence of organic matter, cations and surfactants on the antimicrobial activity of Melaleuca alternifolia (tea tree) oil in vitro. J Appl Microbiol 1999: 86: 446-452.
12. International Organization or Standardisation. ISO 4730:1996: oil of Melaleuca, terpinen-4-ol type (tea tree oil). Geneva: International Organization or Standardisation, 1996.
13. Jandourek A, Vaishampayan JK, Vazquez JA. Efficacy of Melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients. AIDS 1998: 12: 1033-1037.
14. Koh KJ, Pearce AL, Marshman G, Finlay-Jones JJ, Hart PH. Tea tree oil reduces histamine-induced skin inflammation. Br J Dermatol 2002: 147: 1212-1217.
15. Kulik E, Lenkeit K, Meyer J. Antimicrobial activity of tea tree oil (Melaleuca alternifolia) against oral microorganisms. Acta Med Dent Helv 2000: 5: 125-130.
16. Penfold AR, Morrison FR. Some notes on the essential oil of Melaleuca alternifolia. Australas J Pharm 1937: 18: 274-275.
17. Pitten FA, Kramer A. Antimicrobial efficacy of antiseptic mouthrinse solutions. Eur J Clin Pharmacol 1999: 55: 95-100.
18. Sato S, Yoshinuma N, Ito K, Tokumoto T, Takiguchi T, Suzuki Y, et al. The inhibitory effect of furoran and eucalyptus extract-containing chewing gum on plaque formation. J Oral Sci 1998: 40: 115-117.
19. Shapiro S, Meier A, Guggenheim B. The antimicrobial activity of essential oils and essential oil components towards oral bacteria. Oral Microbiol Immunol 1994: 9: 202-208.
20. Summanen P, Baron EJ, Citron DM, Strong C, Wexler HM, Finegold SM. Wadsworth anaerobic bacteriology manual, 3rd edn. Belmont: Star Publishing Company, 1993.
21. Takahashi K, Fukuzawa M, Motohira H, Ochiai K, Nishikawa H, Miyata T. A pilot study on antiplaque effects of mastic chewing gum in the oral cavity. J Periodontol 2003: 40: 501-505.
22. Vazquez JA, Zawawi AA. Efficacy of alcohol-based and alcohol-free Melaleuca oral solution for the treatment of fluconazole-refractory oral candidiasis in patients with AIDS. AIDS 2002: 12: 1033-1037.
23. Walsh LJ, Longstaff J. The antimicrobial effects of an essential oil on selected oral pathogens. Periodontology 1987: 8: 11-15.
24. Wu CD, Savitt ED. Evaluation of the safety and efficacy of over-the-counter oral hygiene products for the reduction and control of plaque and gingivitis. Periodontol 2000 2002: 28: 91-105.